Cargando…
Clinical Prognostic Factors and Integrated Multi-Omics Studies Identify Potential Novel Therapeutic Targets for Pediatric Desmoid Tumor
BACKGROUND: Desmoid tumor (DT), also known as desmoid-type fibromatosis (DTF) or aggressive fibromatosis (AF) is a rare mesenchymal tumor affecting both children and adults. It is non-metastasis but infiltrative, growing with a high recurrence rate to even cause serious health problems. This study i...
Autores principales: | Ning, Bo, Huang, Peng, Zhu, Lining, Ma, Zhijie, Chen, Xiaoli, Xu, Haojun, Ma, Ruixue, Yao, Chengyun, Zheng, Pengfei, Xia, Tian, Xia, Hongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768966/ https://www.ncbi.nlm.nih.gov/pubmed/36539683 http://dx.doi.org/10.1186/s12575-022-00180-0 |
Ejemplares similares
-
Clinical prognostic factors for pediatric extra-abdominal desmoid tumor: analyses of 66 patients at a single institution
por: Ning, Bo, et al.
Publicado: (2018) -
RHOJ Induces Epithelial-to-Mesenchymal Transition by IL-6/STAT3 to Promote Invasion and Metastasis in Gastric Cancer
por: Ma, Zhijie, et al.
Publicado: (2023) -
Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
por: Chen, Hongjin, et al.
Publicado: (2021) -
Desmoid Tumors in the Pediatric Population
por: Honeyman, Joshua N., et al.
Publicado: (2012) -
RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways
por: Wang, Mei, et al.
Publicado: (2022)